Metered Dose Inhaler (MDI) Technology: 2-Day Seminar (London, United Kingdom - February 20-21, 2019) - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Dec 7, 2018--The “Metered Dose Inhaler (MDI) Technology” conference has been added to ResearchAndMarkets.com’s offering.
A comprehensive overview of MDIs including development, manufacture, regulation and market potential
This interactive seminar will provide a comprehensive overview of metered-dose inhaler technology. It will clarify the therapeutic targets and look at delivery technologies. Participants will gain a valuable insight into market potential and receive detailed information on the manufacturing process, quality and inspection requirements and the regulatory pathways to follow.
This seminar will be beneficial for those new to the area and those who require a refresher on the opportunities with this technology. The seminar format will include practical workshops and there will be plenty of opportunity for discussion with the trainer who has significant experience in this field.
Programme Day One
Therapeutic targetsVery brief history Asthma COPD Other local CF Systemic Why? Why not? Key characteristics Particle size Why?
MarketsDisease distribution Historic Current Future Drivers Manufacture vs use International procurement - Double and triple counting Regulation Geographic differences Pricing vs cost vs market - vs product
Delivery technologiesInhalation MDI DPI: unit dose, multi-dose, reservoir Nebuliser: energy source, SMI, other Other Oral Injectable - Nasal Cost considerations - Design Scale Investment Cost of goods Typical breakdown Sensitivities
WorkshopRanking of competitive technologies for different opportunities
Programme Day Two
The MDI - overviewHardware Valves Canister Actuators Sources Formulations Solution Suspensions Other
The MDI - manufacturing processProcess Single-stage Multi-stage Cold Flow Areas
The MDI - manufacturing equipmentScale Lab Small Medium Large
The MDI - quality and inspectionIncoming Release
The MDI - other performancePrime and re-prime Thermal
Challenges and opportunities for the MDI - development and technicalPerformance Stability Compatibility Hardware availability Manufacturing processes/equipment
Challenges and opportunities for the MDI and DPICo-ordination Breath actuation Training Breath co-ordination Deposition Spacers Holding chambers Enhancements Changing therapeutic approaches Once daily Combinations
Workshop (including coffee break)SWOT MDI vs multi-dose DPI SWOT MDI vs Soft Mist Inhaler
Regulation of inhalation productsRegulatory landscape (EU, US, RoW) Generic New combination New chemical entity Time to market Success rate Key expectations Changing environment Combination product approaches Human factors Bioequivalence
For more information about this conference visit https://www.researchandmarkets.com/research/qfxzrf/metered_dose?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181207005493/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Inhalers and Nebulisers,Respiratory Devices
KEYWORD: UNITED KINGDOM EUROPE
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 12/07/2018 02:21 PM/DISC: 12/07/2018 02:21 PM